Story thread · 3 reports / 3 sources
Immunology Drugmaker Electra Seeks to Raise $347 Million in IPO
bloomberg.com · 23h · first report
Electra Therapeutics Inc., a clinical-stage developer of immunology drugs, is seeking to raise as much as $347 million in a US initial public offering.
The coverage
- Electra aims for nearly $300M IPO; Enhertu's Phase 3 lung cancer success
endpts.com · 19h
- Electra Therapeutics targets $977.6 million valuation in US IPO
finance.yahoo.com · 23h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.